S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
3 lithium stocks to ride a multi-year cycle
Is Gold Really Boring? (Ad)
Goldman upgraded Nvidia stock, one metric says it could go higher
Autozone stock price is still in the rally zone
Critical asset just had biggest fall on record (Ad)
New highs are coming for Lowe’s stock despite mixed results
Closing prices for crude oil, gold and other commodities
Is Gold Really Boring? (Ad)
Consumer confidence slips in February as anxiety over potential recession surprisingly reappears
Beyond Meat's shares soar on better-than-expected Q4 revenue despite weak US sales
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
3 lithium stocks to ride a multi-year cycle
Is Gold Really Boring? (Ad)
Goldman upgraded Nvidia stock, one metric says it could go higher
Autozone stock price is still in the rally zone
Critical asset just had biggest fall on record (Ad)
New highs are coming for Lowe’s stock despite mixed results
Closing prices for crude oil, gold and other commodities
Is Gold Really Boring? (Ad)
Consumer confidence slips in February as anxiety over potential recession surprisingly reappears
Beyond Meat's shares soar on better-than-expected Q4 revenue despite weak US sales
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
3 lithium stocks to ride a multi-year cycle
Is Gold Really Boring? (Ad)
Goldman upgraded Nvidia stock, one metric says it could go higher
Autozone stock price is still in the rally zone
Critical asset just had biggest fall on record (Ad)
New highs are coming for Lowe’s stock despite mixed results
Closing prices for crude oil, gold and other commodities
Is Gold Really Boring? (Ad)
Consumer confidence slips in February as anxiety over potential recession surprisingly reappears
Beyond Meat's shares soar on better-than-expected Q4 revenue despite weak US sales
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
3 lithium stocks to ride a multi-year cycle
Is Gold Really Boring? (Ad)
Goldman upgraded Nvidia stock, one metric says it could go higher
Autozone stock price is still in the rally zone
Critical asset just had biggest fall on record (Ad)
New highs are coming for Lowe’s stock despite mixed results
Closing prices for crude oil, gold and other commodities
Is Gold Really Boring? (Ad)
Consumer confidence slips in February as anxiety over potential recession surprisingly reappears
Beyond Meat's shares soar on better-than-expected Q4 revenue despite weak US sales
OTCMKTS:NSTM

NovelStem International (NSTM) Stock Price, News & Analysis

$0.07
0.00 (0.00%)
(As of 02/27/2024 ET)
Today's Range
$0.07
$0.07
50-Day Range
$0.06
$0.08
52-Week Range
$0.06
$0.28
Volume
N/A
Average Volume
1,751 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

NSTM stock logo

About NovelStem International Stock (OTCMKTS:NSTM)

NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is based in Boca Raton, Florida.

NSTM Stock Price History

NSTM Stock News Headlines

Glencore International
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
NovelStem International Corp. (NSTM)
Novelstem International Corp
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
NovelStem International Corp (NSTM)
See More Headlines
Receive NSTM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NovelStem International and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
2/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Retail stores, not elsewhere classified
Sub-Industry
N/A
Current Symbol
OTCMKTS:NSTM
Employees
15
Year Founded
N/A

Profitability

Net Income
$-770,000.00
Pretax Margin
-19,764.50%

Debt

Sales & Book Value

Annual Sales
$10,000.00
Book Value
$0.04 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.25
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Jan H. Loeb (Age 65)
    Executive Chairman & President
  • Mr. Mitchell Rubenstein (Age 70)
    Co-Founder & Independent Director
  • Ms. Christine Jenkins (Age 61)
    CFO & Secretary
    Comp: $188.92k
  • Mr. David Collins
    Investor Relations Firm, Catalyst IR














NSTM Stock Analysis - Frequently Asked Questions

How have NSTM shares performed in 2024?

NovelStem International's stock was trading at $0.0629 at the beginning of 2024. Since then, NSTM stock has increased by 4.9% and is now trading at $0.0660.
View the best growth stocks for 2024 here
.

How do I buy shares of NovelStem International?

Shares of NSTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:NSTM) was last updated on 2/28/2024 by MarketBeat.com Staff